SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice
dc.contributor.author | Chen, G | |
dc.contributor.author | Zhou, G | |
dc.contributor.author | Zhai, L | |
dc.contributor.author | Bao, X | |
dc.contributor.author | Tiwari, N | |
dc.contributor.author | Li, J | |
dc.contributor.author | Mottillo, E | |
dc.contributor.author | Wang, J | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2024-04-30T14:12:52Z | |
dc.date.available | 2024-04-30T14:12:52Z | |
dc.date.issued | 2024-12-01 | |
dc.identifier.issn | 2399-3642 | |
dc.identifier.issn | 2399-3642 | |
dc.identifier.uri | https://www.ncbi.nlm.nih.gov/pubmed/38347107 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/192883 | en |
dc.description.abstract | Non-alcoholic fatty liver disease is associated with an irregular serine metabolism. Serine hydroxymethyltransferase 2 (SHMT2) is a liver enzyme that breaks down serine into glycine and one-carbon (1C) units critical for liver methylation reactions and overall health. However, the contribution of SHMT2 to hepatic 1C homeostasis and biological functions has yet to be defined in genetically modified animal models. We created a mouse strain with targeted SHMT2 knockout in hepatocytes to investigate this. The absence of SHMT2 increased serine and glycine levels in circulation, decreased liver methylation potential, and increased susceptibility to fatty liver disease. Interestingly, SHMT2-deficient mice developed simultaneous fatty liver, but when fed a diet high in fat, fructose, and cholesterol, they had significantly less inflammation and fibrosis. This study highlights the critical role of SHMT2 in maintaining hepatic 1C homeostasis and its stage-specific functions in the pathogenesis of NAFLD. | |
dc.format.medium | Electronic | |
dc.language | eng | |
dc.publisher | Springer Nature | |
dc.relation.haspart | 173 | |
dc.rights | Licence for published version: Creative Commons Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Animals | |
dc.subject | Mice | |
dc.subject | Fibrosis | |
dc.subject | Glycine | |
dc.subject | Liver Cirrhosis | |
dc.subject | Non-alcoholic Fatty Liver Disease | |
dc.subject | Serine | |
dc.title | SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice | |
dc.type | Article | |
dc.identifier.pmid | 38347107 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/192883/2/SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice.pdf | |
dc.identifier.doi | 10.1038/s42003-024-05861-y | |
dc.identifier.doi | https://dx.doi.org/10.7302/22615 | |
dc.identifier.source | Communications Biology | |
dc.description.version | Accepted version | |
dc.date.updated | 2024-04-30T14:12:41Z | |
dc.identifier.orcid | 0009-0006-0654-0253 | |
dc.identifier.orcid | 0000-0002-3465-1018 | |
dc.identifier.orcid | 0000-0003-4503-5058 | |
dc.description.filedescription | Description of SHMT2 reduces fatty liver but is necessary for liver inflammation and fibrosis in mice.pdf : Published version | |
dc.identifier.volume | 7 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 173 | |
dc.identifier.name-orcid | Chen, G | |
dc.identifier.name-orcid | Zhou, G | |
dc.identifier.name-orcid | Zhai, L; 0009-0006-0654-0253 | |
dc.identifier.name-orcid | Bao, X | |
dc.identifier.name-orcid | Tiwari, N | |
dc.identifier.name-orcid | Li, J | |
dc.identifier.name-orcid | Mottillo, E; 0000-0002-3465-1018 | |
dc.identifier.name-orcid | Wang, J; 0000-0003-4503-5058 | |
dc.working.doi | 10.7302/22615 | en |
dc.owningcollname | Pathology, Department of |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.